Revive Therapeutics Ltd (RVVTF)

[PennyWorld]

Gov... so far this is similar to what happened to another foreign biotech that we all know. A Swiss biotech. Silence and non-progress with the FDA causes southern pps drift. Everything is hanging on whether the trial has success with the primary endpoint. Nothing else matters. Not safety, nor what scientists say. The FDA will only look at the endpoint and whether the trial met it. So the design of the endpoint is KEY. Did they overshoot and set the bar too high? IMO we most likely will not know until the spring/summer of 2023, and there will be more southern drift between now and then. This is painful for the longs who hung in there believing. I've seen this happen with many small bitotechs over and over since the pandemic began. JMHO